[Translation] In patients with essential hypertension whose blood pressure was not controlled after 1 month of dual therapy with perindopril 4 mg/indapamide 1.25 mg, the clinical efficacy and safety of the fixed combination of perindopril 5 mg/indapamide 1.25 mg/amlodipine 5 mg were evaluated compared with the free combination therapy of perindopril 4 mg/indapamide 1.25 mg + amlodipine 5 mg after 2 months of treatment. The study drug dose was adjusted based on the patient's blood pressure control during the study.
A multicenter, randomized, double-blind, 7-month study in China.
在经过培哚普利/吲达帕胺双药治疗后血压未得到控制的高血压患者中,评估培哚普利/吲达帕胺/氨氯地平的疗效和安全性。
[Translation] To evaluate the efficacy and safety of perindopril/indapamide/amlodipine in hypertensive patients whose blood pressure is not controlled after perindopril/indapamide dual therapy.